FDA Inspection 1228523 — Cardio Medical Products

Cardio Medical Products — FEI 2246340

The FDA completed an inspection of Cardio Medical Products on Feb 1, 2024 in Rockaway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 1, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Rockaway, NJ (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1471421 CFR 820.30(c)Design input - Lack of or inadequate procedures
1471521 CFR 820.30(d)Design output - Lack of or inadequate procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.